# CORRESP — atai Life Sciences Luxembourg S.A.  (CIK 0002081043)

> <strong>atai Life Sciences Luxembourg S.A.  (CIK 0002081043) → SEC staff</strong> · filed 2025-09-22 · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001140361-25-035713
- **Form:** CORRESP
- **Filer:** atai Life Sciences Luxembourg S.A.  (CIK 0002081043)
- **CIK:** 0002081043
- **Filed:** 2025-09-22
- **SIC industry:** 2834
- **HQ:** New York, NY

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/2081043/000114036125035713/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2081043&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, atai Life Sciences Luxembourg S.A.  (CIK 0002081043) (CIK 0002081043), filed 2025-09-22, accession 0001140361-25-035713. Retrieved via MORVS 2026-11-19 from https://api.morvs.ai/comment-letter/0001140361-25-035713.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*
